课题基金基金详情
WDR34调控Par3亚细胞定位及表达在胃癌上皮间质转化中的机制研究
结题报告
批准号:
81874184
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
陶凯雄
依托单位:
学科分类:
H1809.肿瘤复发与转移
结题年份:
2022
批准年份:
2018
项目状态:
已结题
项目参与者:
吴川清、刘炜圳、白洁、陈锦皇、石亮、曾祥宇、熊振、万文泽、王涛
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
上皮间质转化(EMT)在胃癌侵袭转移过程中发挥重要作用。胃癌EMT与极性蛋白相关,但极性蛋白Par3是否参与胃癌EMT及其调控机制目前尚无报道。我们的预实验发现:Par3在胃癌细胞中异常定位于胞核且其表达量下降,并参与胃癌EMT;同时,细胞胞浆逆向转运动力蛋白中链WDR34与胃癌EMT相关,且WDR34与Par3相互作用。结合文献及预实验结果提出假设:胃癌细胞中WDR34的高表达促使Par3从胞膜逆向转运至胞核,导致胞膜中Par3减少,同时WDR34通过激活Hh信号负调控胃癌细胞中Par3的表达,从而导致胃癌细胞极性消失,进而增强胃癌EMT。为验证该假设,拟进行以下研究:1.验证Par3异常定位及低表达促进胃癌EMT;2.证实WDR34异常高表达增强胃癌EMT;3、阐明WDR34高表达致使Par3异常定位及低表达进而增强胃癌EMT的机制。本项目的顺利实施将为胃癌的治疗提供新的思路和靶点。
英文摘要
Epithelial mesenchymal transition (EMT) plays an important role in the process of gastric cancer metastasis. The EMT of gastric cancer is associated with polarity proteins. However, whether the polarity protein Par3 contributes to the EMT of gastric cancer is seldom studied. Our preliminary study manifested that Par3 was abnormally localized in the nucleus and the expression has decreased in gastric cancer cells, which might be involved in the EMT process of gastric cancer. Meanwhile, the overexpression of WDR34, an intermediate chain of cytoplasmic dynein2, was associated with the EMT of gastric cancer. The preliminary data suggested that WDR34 bind to Par3. Based on newly published literature and our preliminary data, we hypothesized that the overexpression of WDR34 drives the translocation of Par3 from the tight junction of cell membrane into the nucleus and the down-regulates the expression of Par3 through the Hedgehog signaling pathway, which lead to the loss of cell polarity and EMT of gastric cancer. To verify this hypothesis, following studies are planned: 1. To verify that the aberrant location and decreased expression of Par3 promotes the EMT of gastric cancer. 2. To prove the overexpression of WDR34 promotes the EMT of gastric cancer. 3. To clarify that the overexpression of WDR34 drives the aberrant location and decreased expression of Par3, which impair the EMT of gastric cancer. Our study will provide new strategies and targets for the treatment of gastric cancer.
Gastric cancer (GC) is one of the common and malignant tumors. WDR34 is implicated in the development of multiple cancers. We proved that WDR34 expression was upregulated in GC tissues, while being positively correlated with the clinical stage. Knockdown of WDR34 inhibited GC cell viability and prevented the G1 to S cell cycle transformation. RNA sequencing revealed that WDR34 refers to the cell cycle regulation pathway and is associated with E2F1 expression in GC. It was further confirmed that silencing of WDR34 decreased cell growth in a xenograft model. Mechanically, we showed that WDR34 binds to PABPC1 and regulates its nucleocytoplasmic distribution. Furthermore, PABCP1 may act as an oncogene that directly binds E2F1 mRNA and maintains its stability. WDR34 protects the dynamic nucleocytoplasmic distribution of PABPC1, resulting in E2F1 mRNA stability and translation.Our findings suggest a novel role for WDR34 in GC tumorigenesis and potential therapeutic target for GC.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China
PDGFRA 突变胃肠道间质瘤的临床病理特征和预后:中国的一项大规模、多机构观察性研究
DOI:10.2139/ssrn.3783281
发表时间:2021-02
期刊:Social Science Electronic Publishing
影响因子:--
作者:Chengqi Zhang;Ming Wang;Jian Li;Xiaodong Gao;Bo Zhang;Han Liang;Ye Zhou;Guoqing Liao;Fan Feng;Yanbing Zhou;J Yu;Jun Zhang;Yongjian Zhou;Yingjiang Ye;Jiansi Chen;Qun Zhao;Kuntang Shen;Hui Cao;Kaixiong Tao
通讯作者:Kaixiong Tao
DOI:10.3760/cma.j.cn.441530-20210607-00229
发表时间:2021
期刊:中华胃肠外科杂志
影响因子:--
作者:张鹏;陶凯雄
通讯作者:陶凯雄
DOI:10.3760/cma.j.issn.1673-9752.2019.09.005
发表时间:2019
期刊:中华消化外科杂志
影响因子:--
作者:陶凯雄;白洁;帅晓明;夏泽锋;张睿智
通讯作者:张睿智
DOI:10.3969/j.issn.1003-5591.2019.06.011
发表时间:2019
期刊:腹部外科
影响因子:--
作者:杨文昶;李睿东;张鹏;李承果;林曜;陈鑫;王国斌;陶凯雄
通讯作者:陶凯雄
Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor
术前血小板与淋巴细胞比值升高预示原发性胃肠道间质瘤患者预后不良
DOI:10.1186/s12876-020-01275-2
发表时间:2020-04-22
期刊:BMC GASTROENTEROLOGY
影响因子:2.4
作者:Chang,Wei-Long;Yang,Wen-Chang;Zhang,Peng
通讯作者:Zhang,Peng
PCNA/DHX9/R-loop轴增强奥沙利铂诱导胃癌免疫原性细胞死亡的分子机制研究
  • 批准号:
    82373123
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    陶凯雄
  • 依托单位:
抑制胃癌细胞糖酵解调控PD-L1联合免疫治疗的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2020
  • 负责人:
    陶凯雄
  • 依托单位:
B7-H1/PD-1反向信号在调控胃癌干细胞功能中的机制
  • 批准号:
    81572413
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    陶凯雄
  • 依托单位:
甲基化介导Hp沉默miRNA靶向调控胃癌细胞中B7-H1表达的机制
  • 批准号:
    81172294
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2011
  • 负责人:
    陶凯雄
  • 依托单位:
EDNRB基因甲基化诱导灭活转基因小鼠模型的构建及其在HD发病机制中的研究
  • 批准号:
    30872473
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2008
  • 负责人:
    陶凯雄
  • 依托单位:
国内基金
海外基金